In contrast to lung adenocarcinomas in which activating EGFR mutations result in ligand-independent signaling [39–43], such activating EGFR mutations are infrequent in HNSCC [44, 45]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.